Ping‐Ying Chang

853 total citations
51 papers, 499 citations indexed

About

Ping‐Ying Chang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ping‐Ying Chang has authored 51 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ping‐Ying Chang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Ping‐Ying Chang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Ping‐Ying Chang collaborates with scholars based in Taiwan, United States and China. Ping‐Ying Chang's co-authors include Yi‐Ying Wu, Tzu‐Chuan Huang, Jia-Hong Chen, Wen‐Yen Huang, Cheng‐Li Lin, Chia‐Hung Kao, Ching‐Liang Ho, Ming‐Shen Dai, Yeu‐Chin Chen and Shiue‐Wei Lai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ping‐Ying Chang

47 papers receiving 493 citations

Peers

Ping‐Ying Chang

ONCOL

SURGE

PRM

PMH

Tzu‐Chuan Huang Taiwan

I. Prieto Spain

Weimin Chai China

Hyebin Lee South Korea

Jason Hsieh United States

Carla Canevari Italy

Yu Meng China

Jianghua Wu China

Melanie Quintana United States

Martin Cherk Australia

Tzu‐Chuan Huang Taiwan

Ping‐Ying Chang

152 ×0.9

ONCOL

93 ×0.9

SURGE

57 ×0.6

PRM

62 ×0.8

PMH

45 ×0.6

Citations per year, relative to Ping‐Ying Chang Ping‐Ying Chang (= 1×) peers Tzu‐Chuan Huang

Countries citing papers authored by Ping‐Ying Chang

Since Specialization

Citations

This map shows the geographic impact of Ping‐Ying Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Ying Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Ying Chang more than expected).

Fields of papers citing papers by Ping‐Ying Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐Ying Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Ying Chang. The network helps show where Ping‐Ying Chang may publish in the future.

Co-authorship network of co-authors of Ping‐Ying Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐Ying Chang. A scholar is included among the top collaborators of Ping‐Ying Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐Ying Chang. Ping‐Ying Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hsiao-Chi, Wei-Chou Chang, Chao-Cheng Wu, et al.. (2024). Improving the prediction of patient survival with the aid of residual convolutional neural network (ResNet) in colorectal cancer with unresectable liver metastases treated with bevacizumab-based chemotherapy. Cancer Imaging. 24(1). 165–165. 2 indexed citations

Chang, Wei‐Chou, et al.. (2023). Drug-eluting beads loaded with irinotecan to treat synchronous liver-only metastases of colorectal cancer non-responsive to bevacizumab-based chemotherapy. British Journal of Radiology. 96(1145). 20220767–20220767. 1 indexed citations

Wang, Qiaochu, Chaoyang Chen, Je‐Ming Hu, et al.. (2023). N-glycosylation on Asn-57 is required for the correct HAI-2 protein folding and protease inhibitory activity. Glycobiology. 33(3). 203–214. 3 indexed citations

Su, Yung‐Yeh, Yen‐Feng Chiu, Chung‐Pin Li, et al.. (2021). A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study. British Journal of Cancer. 126(7). 1018–1026. 15 indexed citations

Wu, Yi‐Ying, H. Henry Lai, Tzu‐Chuan Huang, et al.. (2021). Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance. Cell Death and Disease. 12(10). 908–908. 17 indexed citations

Wang, Qiaochu, Shih‐Ming Huang, Jehng-Kang Wang, et al.. (2021). The difference in the intracellular Arg/Lys-rich and EHLVY motifs contributes to distinct subcellular distribution of HAI-1 versus HAI-2. Human Cell. 35(1). 163–178. 3 indexed citations

Chang, Ping‐Ying, Chi‐Hsiang Chung, Wei‐Chou Chang, et al.. (2019). The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study. PLoS ONE. 14(5). e0216828–e0216828. 20 indexed citations

Chang, Ping‐Ying, Wen‐Yen Huang, Cheng‐Li Lin, et al.. (2015). Propranolol Reduces Cancer Risk. Medicine. 94(27). e1097–e1097. 103 indexed citations

Chen, Yuguang, Hsueh-Hsing Pan, Ming‐Shen Dai, et al.. (2015). Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices. Medicine. 94(31). e1298–e1298. 7 indexed citations

10.

Peng, Yi‐Jen, et al.. (2015). Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma. SHILAP Revista de lepidopterología. 2(4). 301–307. 2 indexed citations

11.

Chang, Ping‐Ying, et al.. (2015). Interferon-Alpha Caused Reversible Parkinsonism. Clinical Neuropharmacology. 38(3). 119–120. 1 indexed citations

12.

Lai, Shiue‐Wei, et al.. (2015). Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report. Oncology Letters. 9(4). 1957–1961. 9 indexed citations

13.

Chen, Jia-Hong, Tzu‐Chuan Huang, Yi‐Ying Wu, et al.. (2015). Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma. PLoS ONE. 10(6). e0128905–e0128905. 7 indexed citations

14.

Lo, Cheng‐Hsiang, et al.. (2014). Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization. European Journal of Gastroenterology & Hepatology. 26(3). 345–352. 20 indexed citations

15.

Jen, Yee‐Min, Ching‐Liang Ho, Ming–Shen Dai, et al.. (2012). Improved outcomes in buccal squamous cell carcinoma. Head & Neck. 35(1). 65–71. 12 indexed citations

16.

Chang, Ping‐Ying, et al.. (2011). Should the Pectus Bar be Removed Before Pregnancy? Two Case Reports. The Thoracic and Cardiovascular Surgeon. 59(1). 54–56. 2 indexed citations

17.

Chang, Ping‐Ying, Ming‐Fang Cheng, Herng‐Sheng Lee, Chung-Bao Hsieh, & Nai‐Shun Yao. (2010). Preliminary Experience of Cetuximab in the Treatment of Advanced-Stage Biliary Tract Cancer. Onkologie. 33(1-2). 11–11. 15 indexed citations

18.

Chen, Jia-Hong, et al.. (2010). Retroperitoneal Metastatic Adenocarcinoma Complicated with Necrotizing Fasciitis of the Thigh in a Patient with Advanced Rectal Colon Cancer. Case Reports in Oncology. 3(2). 304–309. 10 indexed citations

19.

Lin, Te‐Yu, et al.. (2009). Lung Cancer Metastatic to the Masticator Space. Onkologie. 32(6). 349–351.

20.

Chang, Ping‐Ying, et al.. (2009). Pyoderma gangrenosum as initial presentation of chronic myelomonocytic leukemia. European Journal Of Haematology. 82(5). 410–410. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact